If you are into IT/Software Sector or say in any sector and can bring overseas contracts (or any domestic business related to the software sector), with a stress on Digital Marketing/Content Writing/Website Development/Reputation Management/SEO/SMM, etc, then you can join me as a partner or associate.
We will give you, the business development portfolio and pay you handsome amounts for your efforts. It does not matter, in which part of the world you are, as long as you can bring businesses. If you are interested, please send me at mail at: firstname.lastname@example.org.
Thursday, May 14, 2015
MSCI Small Cap Index adds 51 securities and deletes 8
Mumbai | May 13, 2015: MSCI Inc on Tuesday announced the results of the May 2015 Semi‐Annual Index Review for the MSCI Equity Indexes – including the MSCI Global Standard, MSCI Global Small Cap and MSCI Micro Cap Indexes.
All changes will be implemented as of the close of May 29, 2015. MSCI Small Cap Index will add Aarti Industries, Ajanta Pharma, Alstom T&D, Asahi India, Blue Dart, Bombay Burmah, Capital First, Century Ply, Cera, Crisil, Crompton, Dalmia Bharat, Dhanuka Agri, Edelweiss, Eveready, Future Retail, HCC, Hitachi, Indoco, Ingersoll, Isgec, Kalpataru, Kansai, Kitex Garments, KRBL, L&T Fin, Motilal Oswal, Marico Kaya, Muthoot, Orient Cem, Persistent, PTC India, Ratnamani Metals, Reliance Infra, Repco Home, Rolta, Schneider, Sharda Crop, Shipla Medicare, Suven Life, Tata Comm, Tata Elxsi, Tata Investment, Texmaco Rail, Timken, Union Bank, Viniti Organics, Wabco, Welspun Ind and Zensar.
Bajaj Finance, Balrampur, Bharat Forge, Britannia, DCM Shriram, PMC Fincorp, Prestige Estates and Tilak Finance will be deleted from MSCI Small Cap Index.
There will be 400 additions to and 292 deletions from the MSCI Global Small Cap Indexes. There will be 391 additions to and 261 deletions from the MSCI Global Investable Market Indexes. For MSCI Global Value and Growth Indexes, the largest additions or style changes from growth to value will be Glaxosmithkline (United Kingdom), Novartis (Switzerland) and Kinder Morgan P (USA).